Perbedaan Kalbe Farma Tbk dan Merck Tbk.: Kalbe Farma Tbk diperdagangkan di Rp720 (kapitalisasi pasar 33 T, volume 24 jam 98,44 jt), sedangkan Merck Tbk. diperdagangkan di Rp3.840 (kapitalisasi pasar 1,7 T, volume 24 jam 37,6 rb). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 19,4× kapitalisasi pasar Merck Tbk., dan Kalbe Farma Tbk lebih aktif diperdagangkan (98,44 jt vs 37,6 rb). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | MERK | |
|---|---|---|
Kapitalisasi Pasar | 33 T | 1,7 T |
Volume | 98,44 jt | 37,6 rb |
Lot | 984,38 rb | 376 |
Perputaran | 70,64 M | 144,47 jt |
Harga Rata-rata | 717,58 | 3.842,23 |
Nilai Transaksi | 70,64 M | 144,47 jt |
Harga Ekuilibrium Indikatif | 720 | 3.840 |
Volume Ekuilibrium Indikatif | 43,62 rb | 7 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →